Jinqi Liu

7PUBLICATIONS
53CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsInnate immunityPredictive and prognostic markersElectrochemical energy storage and conversionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis.

|Feb 24, 2026
Baseline Interleukin-10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease-Modifying Antirheumatic Drug Naive and Anti-Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis.

Jinqi Liu, Yicong Li, Kai Fu

|Dec 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.

Chun Wu, Yanhua Hu, Peter Schafer

|Jan 07, 2021
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.

Dan You, Stephen Hillerman, Gregory Locke

|Jul 06, 2019
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis.

Bhagirath Chaurasia, Trevor S Tippetts, Rafael Mayoral Monibas

|Mar 27, 2019
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance.

Jinqi Liu, Joshua Curtin, Dan You

Pageof 2

Frequent Collaborators

2 joint publications

Roy Fleischmann

2 joint publications

Yoshiya Tanaka

2 joint publications

Paul Emery

2 joint publications

David E Kelley